Chemours
472 hedge funds and large institutions have $3.23B invested in Chemours in 2022 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 101 increasing their positions, 188 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
472
Holders Change
-13
Holders Change %
-2.68%
% of All Funds
7.62%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
68
Increased
101
Reduced
188
Closed
74
Calls
$63.2M
Puts
$75.4M
Net Calls
-$12.2M
Net Calls Change
+$14.6M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$362M |
| 2 |
JPMorgan Chase & Co
New York
|
$88.3M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
$23.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$564M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$63.5M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$36.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
$4.78M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$483K |
| 4 |
AWAM
Appian Way Asset Management
New York
|
$0 |
| 5 |
Amundi
Paris,
France
|
$25.3M |